Episode 59: Type 2 Diabetes – how sweet it isn’t – Part V
In episode 59, the fifth podcast in our diatribe on type-2 diabetes, we finally get to the evidence surrounding specific treatments. The importance of lifestyle is discussed and then the rest of the time is spent talking about the who, what, why, where, and when’s of metformin. James asks lots of rhetorical questions and Mike tries to answer them in a grandiloquent way.
1) UKPDS (original trial)
2) UKPDS (recent results)
3) Metformin’s contraindications should be contraindicated
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!